Showing results (721-730 of 944) with videos related to

Sort By:
Pageof 95
Clinical Therapeutics|December 10, 2014
Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III TrialBecky Schweighardt, Troy Tompkins, Kelly Lau, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2025
Relation of Visual Function, Retinal Thickness by Optical Coherence Tomography, and MRI Brain Volume in Pediatric-Onset Multiple SclerosisAnna Sosa, Kimberly A O'Neill, Ruben Jauregui, et al.
Clinical Immunology (Orlando, Fla.)|September 12, 2018
Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 studyAnu Cherukuri, Heather Cahan, Greg de Hart, et al.
Nucleic Acid Therapeutics|February 7, 2025
BMN 351-Induced Exon Skipping and Dystrophin Expression in Skeletal and Cardiac Muscle Lead to Preservation of Motor Function in a Mouse Model of Exon 51 Skip-Amenable Duchenne Muscular DystrophyTodd Oppeneer, Yulan Qi, Joshua Henshaw, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Assessing task compliance following mobile phone-based video remindersSonja A O'Neill, Guido Parente, Mark P Donnelly, et al.
Critical Reviews in Clinical Laboratory Sciences|March 15, 2022
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the futureFausto Baldanti, Nirmal K Ganguly, Guiqiang Wang, et al.
American Journal of Medical Genetics|April 9, 1996
Irish study on high-density schizophrenia families: field methods and power to detect linkageK S Kendler, F A O'Neill, J Burke, et al.
The Journal of the American Academy of Orthopaedic Surgeons|August 1, 2007
Disasters and mass casualties: II. explosive, biologic, chemical, and nuclear agentsChristopher T Born, Susan M Briggs, David L Ciraulo, et al.
BMC Neurology|March 12, 2021
Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of AgeingR A O'Neill, A P Maxwell, E N Paterson, et al.
Clinical Therapeutics|September 20, 2017
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-oldsIra Gantz, Liubov Sokolova, Lokesh Jain, et al.
Pageof 95